Citigroup’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,200
Closed -$10K 7989
2019
Q1
$10K Buy
15,200
+6,900
+83% +$4.34K ﹤0.01% 7271
2018
Q4
$4K Sell
8,300
-1,400
-14% -$966 ﹤0.01% 7437
2018
Q3
$10K Sell
9,700
-7,200
-43% -$8.13K ﹤0.01% 7371
2018
Q2
$19K Buy
16,900
+3,300
+24% +$4.93K ﹤0.01% 6958
2018
Q1
$22K Buy
13,600
+12,490
+1,125% +$22K ﹤0.01% 6712
2017
Q4
$2K Sell
1,110
-3,940
-78% -$8.15K ﹤0.01% 7446
2017
Q3
$12K Buy
5,050
+733
+17% +$2.48K ﹤0.01% 6648
2017
Q2
$16K Buy
4,317
+734
+20% +$2.51K ﹤0.01% 6370
2017
Q1
$10K Buy
3,583
+1,416
+65% +$3.58K ﹤0.01% 6581
2016
Q4
$5K Buy
2,167
+1,334
+160% +$3.92K ﹤0.01% 6956
2016
Q3
$3K Buy
+833
New +$3.82K ﹤0.01% 6904

Other funds holding CYTR

Citigroup's CYTR Position: Q2 2019 in Review

Citigroup sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 2,135 shares — an estimated $1K sold.

Citigroup first reported a position in CYTR in Q4 2013 and held it in 16 quarters. The position peaked at $146K in Q1 2016. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • Citigroup reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • Citigroup sold 2,135 CytRx Corp shares in Q2 2019, an estimated $1K.
  • Citigroup first reported a position in CytRx Corp in Q4 2013 and held it in 16 quarters.
  • Citigroup's CytRx Corp position peaked at $146K in Q1 2016.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.